Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Amgen's EPO Drugs Dodge a Bullet as Hematide Stumbles, but the Big Biotech's Trials Aren't Over
Amgen's EPO Drugs Dodge a Bullet as Hematide Stumbles, but the Big Biotech's Trials Aren't Over
Amgen's EPO Drugs Dodge a Bullet as Hematide Stumbles, but the Big Biotech's Trials Aren't Over
Submitted by
admin
on June 22, 2010 - 12:31pm
Source:
BNET Pharma
News Tags:
Amgen
Hematide
anemia
Affymax
Takeda
Headline:
Amgen's EPO Drugs Dodge a Bullet as Hematide Stumbles, but the Big Biotech's Trials Aren't Over
Do Not Allow Advertisers to Use My Personal information
